Premia SA
F:3FDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Premia SA
F:3FDA
|
GR |
|
R
|
Resona Holdings Inc
XMUN:DW1
|
JP |
|
Cherry SE
F:C3RY
|
DE |
|
First Nordic Metals Corp
F:HEG0
|
CA |
|
Macerich Co
NYSE:MAC
|
US |
|
M
|
Mitsubishi UFJ Financial Group Inc
XMUN:MFZ
|
JP |
Wall St Price Targets
3FDA Price Targets Summary
Premia SA
According to Wall Street analysts, the average 1-year price target for 3FDA is 1.805 EUR with a low forecast of 1.55 EUR and a high forecast of 2.105 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 3FDA's stock price target?
Price Target
1.805
EUR
According to Wall Street analysts, the average 1-year price target for 3FDA is 1.805 EUR with a low forecast of 1.55 EUR and a high forecast of 2.105 EUR.
What is the Revenue forecast for Premia SA?
Projected CAGR
14%
The compound annual growth rate for Revenue over the next 2 years is 14%.
What is the Operating Income forecast for Premia SA?
Projected CAGR
22%
The compound annual growth rate for Operating Income over the next 2 years is 22%.
What is the Pre-Tax Income forecast for Premia SA?
Projected CAGR
-23%
The compound annual growth rate for Pre-Tax Income over the next 2 years is -23%.
What is the Net Income forecast for Premia SA?
Projected CAGR
-21%
The compound annual growth rate for Net Income over the next 2 years is -21%.
